Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| Reactant | 1-(3-C-Ethynylpentofuranosyl)-4-imino-1,4-dihydropyrimidin-2-ol | HCID 176885 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 24767999 | HCID 24767999 | — |
Reaction Steps
tert-Butyldimethylsilylchloride (12.5 g, 82.5 mmol) was gradually added under ice-cooling to a solution of 3′-ethynylcytidine (hereinafter referred to as ECyd) (20 g, 75 mmol) and imidazole (12.8 g, 188 mmol) in N,N-dimethylformamide (hereinafter referred to as DMF) (75 mL), and the mixture was stirred for 5 hours at room temperature. After completion of reaction, the solvent was evaporated under reduced pressure, and ethyl acetate was added to the residue. The mixture was washed with saturated aqueous sodium hydrogen carbonate (100 mL) and saturated brine (100 mL) and dried with magnesium sulfate. Magnesium sulfate was removed through filtration. The filtrate was stirred at room temperature, and precipitated crystals were collected through filtration, to thereby yield Compound 1 (11.5 g, 52%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08058261B2 |
|---|
| Source dataset | uspto-grants-2011_11 |
|---|
| ORD ID | ord-56c3e20e928d48aab4cdea1f1508c78c |
|---|
| Source note | uspto-grants-2011_11 |
|---|